Monday, August 31, 2017 — Softheon Technologies, which drives measurable medical cost reduction through an innovative prescriptive analytics and consumer engagement platform, today announced that it has been included as one of the vendors profiled in Frost & Sullivan’s 2017 Global Healthcare Data Analytics Companies-to-Action report. According to the analysis, Frost & Sullivan’s Transformational Health team found that vendors that offer solutions across complete healthcare functions or therapeutic areas will be best positioned to harness growth opportunities.
“Frost & Sullivan’s analysis, Global Healthcare Data Analytics Companies-to-Action, 2017, highlights the ecosystem evolution in high-priority digital health markets and profiles notable market players that have the potential to radically transform existing industry paradigms.”
About Softheon Technologies
Softheon Technologies empowers people to make the best healthcare decisions. Our prescriptive analytics and consumer engagement platform has helped innovative health plans such as UnitedHealthcare, BlueCross BlueShield of Tennessee, and Florida Blue reduce medical costs by over $40 PMPM. Scalable to multiple use cases and lines of business, plans know who to target, which programs work, which don’t, and precisely how well – all from a single platform. Outcomes are measured within 10 weeks from deployment and offer in-year ROI. Softheon offers a turn-key managed services contract and puts its fees at risk based delivered outcomes. For more information, visit nexthealthtechnologies.com.
For media inquiries:
Softheon Technologies
Melissa O’Connor
VP, Marketing
moconnor@nexthealthtechnologies.com
